Navigation Links
Human Genome Sciences Appoints David P. Southwell to its Board of Directors
Date:7/24/2008

ROCKVILLE, Md., July 24 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that David P. Southwell has been appointed to the HGS Board of Directors. He will also serve as a member of the Company's Audit Committee. Until recently, Mr. Southwell was at Sepracor, Inc., a research-based pharmaceutical company, where he served as Executive Vice President and Chief Financial Officer, and also had responsibility for Corporate Planning, Development and Licensing.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO

"David Southwell brings more than twenty years of experience and significant accomplishment to HGS in financial strategy, planning and business development," said H. Thomas Watkins, President and Chief Executive Officer, HGS. "We look forward to benefiting from David's experience and insight as we continue our transformation into a fully commercial biopharmaceutical company. We are pleased to welcome him to our Board."

During his fourteen-year tenure at Sepracor, Mr. Southwell advanced through a series of senior management positions with increasing responsibility in finance, corporate planning, development and licensing. He was responsible for raising approximately $3 billion through public equity offerings and private placements of convertible debt securities. Prior to joining Sepracor, Mr. Southwell was Vice President, Investment Banking Division, at Lehman Brothers in New York.

Mr. Southwell graduated from Rice University, and received his M.B.A. from the Tuck School of Business at Dartmouth College. Mr. Southwell serves as Chairman of the Board of Directors for BioSphere Medical, Inc.
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)
2. New Initiative Has Shocking Effect: Thousands of Missourians with Abnormal Chromosome Structures Are Not Human
3. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
4. Human Genome Sciences Announces $40 Million Milestone Payment Related to Albuferon(R) Development
5. Novocell Announces Discovery Linking Key Cancer Cell Signaling Pathways With Proliferation and Self-Renewal of Human Embryonic Stem Cells
6. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
8. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bear Stearns Conference
9. Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
10. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference
11. Premier Research Appoints Global Head of Human Resources

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...Newswire/ -- Karolinska Development AB today,annou...ntered into a,co-investment agreement with the com...rolinska Development and used to invest in the com... medical technology companies. EIF,has agreed to i...agreement,represents EIF,s largest single investme...
(Date:11/19/2009)...ge their cell phones and other personal electronic...de by UC San Diego engineers could lead to carbon ...this. , In recent research, published in Appli...r in the UCSD Department of Mechanical and Aerospa...oefer, have found that artificially introduced def...
(Date:11/19/2009)... Spherix Incorporated (N...diabetes therapy, and a provider of technical and ..., biotechnology and pharmaceutical companies, anno... million registered direct placement to institutio...ock and warrants to purchase up to 1,104,348 addit...
(Date:11/19/2009)...19 MONITORING FORCE GmbH,announced...nserin in the,indication treatment-relevant levodo...rphan drug status designation with the European Me... is a complication of the mainstay,treatment in ad... those,affected, since it may be disabling for the...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Nanotube defects equal better energy and storage systems 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 2Spherix Announces the Closing of $6.3 Million Registered Direct Offering 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
...y, March 10, 2008 at 8:30am, NEW YORK, March 10 ... Inc. (Nasdaq: KERX ), announced top-line results...nex (sulodexide) for the,treatment of diabetic nep...clinical trial failed to meet the primary objectiv...on of patients that achieve therapeutic success at...
...va, Inc. (Nasdaq: ANSV ) today announced that the...lication (sNDA) with the U.S. Food and Drug,Admini...to treat the pain,associated with peripheral IV in...ocaine hydrochloride monohydrate) powder intraderm... to provide local analgesia,prior to peripheral IV...
...rted, communicated in late 2007 ...tho Biotech Products, L.P.,today modified prescrib...owing guidance from the U.S. Food and Drug Adminis...hin the erythropoiesis-stimulating agent,(ESA) cla...unplanned interim analysis,of Amgen,s PREPARE stud...
Other Biology Technology:Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint 2Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint 3Keryx Biopharmaceuticals Announces that SUN-MICRO Phase 3 Clinical Trial Fails to Meet Primary Efficacy Endpoint 4Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults 2Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults 3Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults 4Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 2Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 3Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 4Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 5Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 6Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 7
(Date:11/20/2009)... a group of University of Oklahoma researchers wer... the human genome project. Today, the OU Advance...an international effort to sequence the tomato gen...nal Science Foundation for plant genomics. , "T...o improving the tomato and crop yields will improv...
(Date:11/20/2009)...tion in the origin of biological molecules like RN... of years ago from simple precursors. Now, in a st...taly have reconstructed one of the earliest evolut...om individual subunits using nothing but warm wate...of the first biological molecules present, before ...
(Date:11/20/2009)...oduction of a single bacterial gene into yeast, re...he Netherlands achieved three improvements in bioe...: ,More ethanol, less acetate and elimination of t...ion was published in the scientific journal Appli... , Bioethanol is made by the yeast Saccharomyces...
Breaking Biology News(10 mins):NSF awards $7.5M grant to University of Oklahoma for plant genomics 2Delft breakthrough in bioethanol production from agricultural waste 2Nanyang Technological University and UK partners heightens cooperation in water industry 10235 1Nanyang Technological University and UK partners heightens cooperation in water industry 10235 2Nanyang Technological University and UK partners heightens cooperation in water industry 10235 3Study Counters Warnings on Quit Smoking Drug 58757 1Study Counters Warnings on Quit Smoking Drug 58757 2Leading Baltimore Plastic Surgeons Join Plastic Surgery Portal Network 58752 1Leading Baltimore Plastic Surgeons Join Plastic Surgery Portal Network 58752 2
...cialist II, and Linheng Li, Ph.D., Associate Inves...ely, on a new publication that clarifies how norma...er stem cells can cause the formation of tumors. ... initiate intestinal polyposis" was posted to the ...theory that cancer stem cells initiate and drive c...
... active older adults infected with HIV has unprote...researchers. A survey of 260 HIV-positive older ad...e, took Viagra and were in a relationship. , AIDs ...03. According to the Centers for Disease Control a...IV/AIDS cases in the United States by 2015 because...
...stopped in its tracks a form of blood cancer in mi...merase, thereby shortening the ends of chromosomes...t critically short, the cell commits suicide as a ... Ph.D., the Daniel Nathans chair of molecular biol...aring online this month at Cancer Cell, uncovers a...
Other Biology News:Linheng Li Lab documents the development of cancer stem cells 21/3 of sexually active older adults with HIV/AIDs has unprotected sex 2Short chromosomes put cancer cells in forced rest 2
ApopTag Fluorescein In Situ Apoptosis Detection Kit from CHEMICON
...lor staining method for labeling DNA breaks and to... cytometry. The kit contains the instructions and ... including: positive and negative control cells fo... and rinsing buffers for processing individual ste...
...s a two color staining method for labeling DNA br...lls by flow cytometry. The kit contains the instr...sis in cells including; positive and negative cont...ng, reaction, and rinsing buffers for processing i...
PowerPac HV Power Supply With Temperature Probe from Bio-Rad
Biology Products: